Task: Answer the multiple-choice question.
Question: Which compound exhibits a 8.242\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. O=C(CNc1cccc(S(=O)(=O)N2CCOCC2)c1)Nc1ccc(C(F)(F)F)cc1
b. Cc1ccc(NC(=O)CCn2nc([N+](=O)[O-])cc2C)nc1
c. Cc1cc(=O)[nH]c2c(C)c(N)ccc12
d. Cc1cc(=O)oc2cc(OC(C)C(=O)Nc3ccc(C(N)=O)cc3)ccc12
e. CCC(CC)C(=O)OCC(=O)Nc1cccc(S(=O)(=O)N(C)c2ccccc2)c1
Answer: b. Cc1ccc(NC(=O)CCn2nc([N+](=O)[O-])cc2C)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)CCn2nc([N+](=O)[O-])cc2C)nc1
Cc1ccc(NC(=O)CCn2nc([N+](=O)[O-])cc2C)nc1
[5-methyl-1-[3-[(5-methylpyridin-2-yl)amino]-3-oxopropyl]pyrazol-3-yl]-oxido-oxoazanium